Gene therapy in peripheral artery disease

Current Drug Targets - Cardiovascular and Haematological Disorders

Volumn 4, Issue 3, 2004, Pages 295-300

  Melillo, G ^a   Serino, F ^a   Cirielli, C ^a   Capogrossi, M C ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Angiogenesis; Clinical trial; Gene therapy; Growth factors; Peripheral arterial obstructive disease

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; ADENOVIRUS VECTOR; ANGIOGENIC FACTOR; ANGIOPOIETIN 1; BASIC FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 4; GROWTH FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; NAKED DNA; NEW DRUG; PLACEBO; PROSTACYCLIN SYNTHASE; SCATTER FACTOR; SOMATOMEDIN; VASCULOTROPIN;

ANGIOGENESIS; ARTERY DISEASE; BUERGER DISEASE; CLINICAL TRIAL; COLLATERAL CIRCULATION; DRUG SAFETY; EXPRESSION VECTOR; GENE TARGETING; GENE THERAPY; GENETIC TRANSFECTION; HEART MUSCLE ISCHEMIA; HUMAN; INJECTION PAIN; LIMB ISCHEMIA; NONHUMAN; PERIPHERAL EDEMA; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; REVIEW; SINGLE DRUG DOSE; VASCULARIZATION;

ANIMALS; CLINICAL TRIALS; GENE THERAPY; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; PERIPHERAL VASCULAR DISEASES;

EID: 4444373079     PISSN: 15680061     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568006043336023     Document Type: Review

References (36)

1. Second European Consensus Document on Chronic Critical Leg Ischemia. Circulation 1991, 84 (suppl. IV), IV-1-IV-26.
2. Dormandy, J.; Mahir, M.; Ascady, G.; Balsano, F.; De Leeuw, P.; Blombery, P.; Bousser, M.G.; Glement, D.; Coffman, J.; Deutshinoff, A. Fate of the patient with chronic leg ischaemia. J. Cardiovasc. Surg., 1989, 30, 50-57.
3. Rutherford, R.B.; Flanigan, D.P.; Gupta, S.K.; on behalf of the Ad Hoc Committee on Reporting Standards. Society for Vascular Surgery/North American Chapter, International Society for Cardiovascular Surgery. Suggested standards for reports dealing with lower extremity ischemia. Ad Hoc Committee on Reporting Standards. Society for Vascular Surgery/North American Chapter, International Society for Cardiovascular Surgery. J. Vasc. Surg., 1986, 4, 80-94.
4. Tyrrell, M.R.; Wolfe, J.H. Critical leg ischaemia, an appraisal of clinical definitions. Joint Vascular Research Group. Br. J. Surg., 1993, 80, 177-180.
5. Muhlhauser, J.; Merrill, M.J.; Pili, R.; Maeda, H.; Bacic, M.; Bewig, B.; Passaniti, A.; Edwards, N.A.; Crystal, R.G.; Capogrossi, M.C. VEGF165 expressed by a replication-deficient recombinant adenovirus vector induces angiogenesis in vivo. Circ. Res., 1995, 77, 1077-1086.
6. Muhlhauser, J.; Pili, R.; Merrill, M.J.; Maeda, H.; Passaniti, A.; Crystal, R.G.; Capogrossi, M.C. In vivo angiogenesis induced by recombinant adenovirus vectors coding either for secreted or nonsecreted forms of acidic fibroblast growth factor. Hum. Gene Ther., 1995, 11, 1457-1465.
7. Hershey, J.C.; Baskin, E.P.; Glass, J.D.; Hartman, H.A.; Gilberto, D.B.; Rogers, I.T.; Cook, J.J. Revascularization in the rabbit hindlimb: dissociation between capillary sprouting and arteriogenesis.Cardiovasc. Res., 2001, 49, 618-625
8. Lindner, V. and Maciag, T. The putative convergent and divergent natures of angiogenesis and arteriogenesis. Circ. Res., 2001, 89, 747-749.
9. Deindl, E.; Bushmann, I.; Hoefer, I.E.; Podzuweit, T.; Boengler, K.; Vogel, S.; Van Royen, N.; Fernandez, B.; Schaper, W. Role of ischemia and of hypoxia-inducible genes in arteriogenesis after femoral artery occlusion in the rabbit. Circ. Res., 2001, 89, 779-786.
10. Arras, M.; Ito, W.D.; Scholz, D.; Winkler, B.; Schaper, J.; Schaper, W. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J. Clin. Invest., 1998, 101, 40-50.
11. Ito, W.D.; Arras, M.; Winkler, B.; Scholz, D.; Schaper, H.; Schaper, W. Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion. Circ. Res., 1997, 80, 829-837.
12. Melillo, G.; Scoccianti, M.; Kovesdi, I.; Safi, J. Jr.; Riccioni, T.; Capogrossi, M.C. Gene therapy for collateral vessel development. Cardiovasc. Res., 1997, 35, 480-489.
13. Carmeliet, P. Mechanisms of angiogenesis and arteriogenesis. Nature Med., 2000, 6, 389-395.
14. Rissanen, T.T.; Markkanen, J.E.; Arve, K.; Rutanen, J.; Kettunen, M.I.; Vajanto, I.; Jauhiainen, S.; Cashion, L.; Gruchala, M.; Narvanen, O.; Taipale, P.; Kauppinen, R.A.; Rubanyi, G.M.; Yla-Herttuala, S. Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model. The FASEB Journal, 2003, 17(1), 100-102.
15. Koike, H.; Morishita, R.; Iguchi, S.; Aoki, M.; Matsumoto, K.; Nakamura, T.; Yokoyama, C.; Tanabe, T.; Ogihara, T.; Kaneda, Y. Enhanced angiogenesis and improvement of neuropathy by cotransfection of human hepatocyte growth factor and prostacyclin synthase gene The FASEB Journal, express article Published online, 2003, 10.1096/fj.02-0754fje.
16. Su, E.J.; Cioffi, C.L.; Stefansson, S.; Mittereder, N.; Garay, M.; Hreniuk, D.; Liau, G. gene therapy vector-mediated expression of insulin-like growth factors protects cardiomyocytes from apoptosis and enhances neovascularization Am. J. Physiol. Heart Circ. Physiol., 2002, 10, 1152.
17. Vincent, K. A.; Shyu, K. G.; Luo, Y.; Magner, M.; Tio, R. A.; Jiang, C.; Goldberg, M. A.; Akita, G. Y.; Gregory, R. J.; Isner, J. M. Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked dna encoding an HIF-1a/vp16 hybrid transcription factor Circulation, 2000, 102, 2255-2261.
18. Babaei, S.; Stewart, D.J. Overexpression of endothelial NO synthase induces angiogenesis in a co-culture model. Cardiovasc. Res., 2002, 55, 190-200.
19. Taniyama, Y.; Tachibana, K.; Hiraoka, K.; Aoki, M.; Yamamoto, S.; Matsumoto, K.; Nakamura, T.; Ogihara, T.; Kaneda, Y.; Morishita, R. Development of safe and efficient novel nonviral gene transfer using ultrasound.; enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther., 2002, 9, 372-380.
20. Masaki, I.; Yonemitsu, Y.; Yamashita, A.; Sata, S.; Tanii, M.; Komori, K.; Nakagawa, K.; Hou, X.; Nagai, Y.; Hasegawa, M.; Sugimachi, K.; Sueishi, K. Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2. Circ. Res., 2002, 90, 966-973.
21. Gowdak, L.H.; Poliakova, L.; Wang, X.; Kovesdi, I.; Fishbein, K.W.; Zacheo, A.; Palumbo, R.; Straino, S.; Emanueli, C.; Marrocco-Trischitta, M.; Lakatta, E.G.; Anversa, P.; Spencer, R.G.; Talan, M.; Capogrossi, M.C. Adenovirus-mediated VEGF(121) gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia. Circulation, 2000, 102, 565-571.
22. Isner, J.M.; Pieczek, A.; Schainfeld, R.; Blair, R.; Haley, L.; Asahara, T.; Rosenfield, K.; Razvi, S.; Walsh, K.; Symes, J.F. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet, 1996, 348, 370-374.
23. Baumgartner, I.; Pieczek, A.; Manor, O.; Blair, R.; Kearney, M.; Walsh, K.; Isner, J.M. Circulation, 1998, 97, 1114-1123.
24. Isner, J.M.; Baumgartner, I.; Rauh, G.; Schainfeld, R.; Blair, R.; Manor, O.; Razvi, S.; Symes, J.F. J. Vasc. Surg., 1998, 6, 964-973.
25. Simovic, D.; Isner, J.M.; Ropper, A.H.; Pieczek, A.; Weinberg, D.H. Improvement in chronic ischemic neuropathy after intramuscular phVEGF165 gene transfer in patients with critical limb ischemia. Arch. Neurol., 2001, 58, 761-768.
26. Shyu, K.G.; Chang, H.; Wang, B.W.; Kuan, P. Intramuscular vascular endothelial growth factor gene therapy in patients with chronic critical leg ischemia. Am. J. Med., 2003, 114, 156-7.
27. Rajagopalan, S.; Trachtenberg, J.; Mohler, E.; Olin, J.; McBride, S.; Pak, R.; Rasmussen, H.; Crystal, R. Phase I study of direct administration of a replication deficient adenovirus vector containing the vascular endothelial growth factor cDNA (CI-1023) to patients with claudication. Am. J. Cardiol., 2002, 90, 512-516.
28. Rajagopalan, S.; Shah, M.; Luciano, A.; Crystal, R.; Nabel, E.G. Adenovirus-mediated gene transfer of VEGF(121) improves lower-extremity endothelial function and flow reserve. Circulation, 2001, 104, 753-755.
29. Rajagopalan, S.; Mohler, E.R. 3rd.; Lederman, R.J.; Mendelsohn, F.O.; Saucedo, J.F.; Goldman, C.K.; Blebea, J.; Macko, J.; Kessler, P.D.; Rasmussen, H.S.; Annex, B.H. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation, 2003, 108, 1933-1938.
30. Comerota, A.J.; Throm, R.C.; Miller, K.A.; Henry, T.; Chronos, N.; Laird, J.; Sequeira, R.; Kent, C.K.; Bacchetta, M.; Goldman, C.; Salenius, J.P.; Schmieder, F.A.; Pilsudski, R. Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia.; preliminary results of a phase I trial. J. Vasc. Surg., 2002, 35, 930-936.
31. Harvey, B.G.; Maroni, J.; O'Donoghue, K.A.; Chu, K.W.; Muscat, J.C.; Pippo, A.L.; Wright, C.E.; Hollmann, C.; Wisnivesky, J.P.; Kessler, P.D.; Rasmussen, H.S.; Rosengart, T.K.; Crystal, R.G. Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions. Hum. Gene Ther., 2002, 13, 15-63.
32. Crystal, R.G.; Harvey, B.G.; Wisnivesky, J.P.; O'Donoghue, K.A.; Chu, K.W.; Maroni, J.; Muscat, J.C.; Pippo, A.L.; Wright, C.E.; Kaner, R.J.; Leopold, P.L.; Kessler, P.D.; Rasmussen, H.S.; Rosengart, T.K.; Hollmann, C. Analysis of risk factors for local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions. Hum. Gene Ther., 2002, 13, 65-100.
33. Tateishi Yuyama, E.; Matsubara, H.; Moruhara, T.; Ikeda, U.; Shintani, S.; Masaki, H.; Armano, K.; Kishimoto, Y.; Yoshimoto, K.; Akashi, H.; Shimada, K.; Iwasaka, T.; Imaizumi, T. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet, 2002, 360, 427-435.
34. Carmeliet, P. Angiogenesis in health and disease. Nature Medicine, 2003, 9, 653-660.
35. Kain, R.K. Molecular regulation of vessel maturation. Nature Medicine, 2003, 9, 685-693.
36. Yla-Herttuala Alitalo, K. Gene transfer as a tool to induce therapeutic vascular growth. Nature Medicine, 2003, 9, 694-701.